1GELDERBLOM H, VERWEI J J, NOOTER K,et al. The drawbacks and advantages of vehicle selection for drug formulation [ J ]. Eur J Cancer,2001,37(13) :1590.
2ABU-KHALAF M M, JUNEJ A V, CHUNG G G,et al. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T) , and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer [J]. Breast Cancer Res Treat.2007.104 (3) ,341.
3ARMSTRONG D K, BOOKMAN M A, MCGUIRE W,et al. A phase I study of paclitaxel, topotecan, cisplatin and filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 2007, 105 (3) :667.
5PERKINS C L, FANG G, KIM C N. The role of Apaf-1, caspase-9, and bid proteins in etoposide-or paclitaxel-induced mitochondrial events during apoptosis[ J]. Cancer Res,2000,60 (6) :1645.
6SYMMANS W F, VOLOM M D, SHAPIRO R L, et al. Paclitaxelinduced apoptosis and mitotic arrest assessed by serial fine-needle aspiration : implications for early prediction of breast cancer response to neoadjuvant treatment[J]. Clin Cancer Res,2000 ,6 (12) :4610.
7KLAUBER N, PARANGI S, FLYNN E, et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2- methoxyestradiol and taxol [ J ]. Cancer Res, 1997,57 ( 1 ) : 81.
8PARK D C, KI J H, LEW Y O, et al. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer[ J ]. Gynecol Oncol, 92(1) :59.
9DAVID H, MOORE J A,BLESSING R P,et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study [ J ]. J Clin Oncol, 2004,22 ( 15 ) : 3113.
1van Nagell Jr J,Rayburn W,Donaldson ES,et al.Therapeutic implications of patterns of recurrence in cancer of the uterine cervix.[J] Cancer,1979,44(6):2354-2361.
2Friedlander M,Grogan M.U.S.Preventative Services Task Force.Guidelines for the treatment of recurrent and metastatic cervical cancer[J].Oncologist,2002,7(4):342-347.
3Moore DH,Blessing JA,McQuellon RP,et al.Phase Ⅲ study of cisplatin with or without paclitaxel in stage IVB,recurrent,or persistent squamous cell carcinoma of the cervix:a gynecologic oncology group study[J].J Clin Oncolo,2004,22(15):3113-3119.
4Hainsworth JD,Burris HA,Erland JR,et al.Phase Ⅰ study of docetaxol administered by weekly infusion in patients with advanced refractory cancer[J].J Clin Oncol,1998,16(6):2164-2168.
5Piver MS,Ghamande SA.Eltabbakh G.First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervixaphase Ⅱ study[J].Gynecol Oncol,1999,75 (3):334-337.
6Duenas-Gonzalez A,Lopez-Graniel C,Gonzalez-Enciso A,et al.A phase Ⅱ study of multimodality treatment for locally advanced cervical cancer:neoadjuvant carboplatin and paclitaxel followed by radical-hysterectomy and adjuvant cisplatin chemoradiation[J].Ann Oncol,2003,14 (8):1278-1284.
2Xing Wang Wang~1 Jin Hui Yuan~1 Ru Gang Zhang~1 Li Xia Guo~1 Yong Xie~2 Hong Xie~1 ~1Department of Biotherapy,Shanghai Institute of Cell Biology,Chinese Academy of Sciences,Shanghai 200031,China ~2Department of Biology,Hong Kong University of Science and Technology,ChinaDr.Xing Wang Wang earned Ph.D.from Shanghai Institute of Materia Medical,Chinese Academy of Sciences in 1997.Now a professor at Shanghai Institute of Cell Biology,Chinese Academy of Sciences..Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice[J].World Journal of Gastroenterology,2001,7(3):345-351. 被引量：21
3Li Ping Wang~1 Ke Liang~2 Yu Shen~2 Wei Bo Yin~2 G.Hans~3 Yan Jun Zeng~1 ~1Biomechanics & Medical Information Institute,Beijing Polytechnic University,Beijng 100022,China ~2Department of Gastrointestinal Surgery,Aalborg University,Denmark ~3Cancer Institute (Hospital),Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,ChinaLi Ping Wang graduated from Beijing Polytechnic University in 2000,major in tumor radiotherapy,having 3 papers published..Neutron-induced apoptosis of HR8348 cells in vitro[J].World Journal of Gastroenterology,2001,7(3):435-439. 被引量：5
4Du-Hu Liu Xue-Yong Zhang Dai-Ming Fan Yu-Xin Huang Jin-Shan Zhang Wei-Quan Huang Yuan-Qiang Zhang Qing-Sheng Huang Wen-Yu Ma Yu-Bo Chai Ming Jin Institute of Digestive Disease,Xijing Hospital,~2 Department of Gastroenterology,Tangdu Hospital,~3Department of Histology and Embryology,~4 Department of Microbiology,~5 Department of Biochemistry,Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China.Expression of vascular endothelial growth factor and its role in oncogenesis of human gastric carcinoma[J].World Journal of Gastroenterology,2001,7(4):500-505. 被引量：37
